Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Alcoholics Anonymous
Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient data (IPD) analysis.
Evidence-based role of bevacizumab in non-small cell lung cancer.
Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Evidence-based role of bevacizumab in non-small cell lung cancer.
Evidence-based role of bevacizumab in non-small cell lung cancer. Ann Oncol. 2013 Jan; 24(1):6-9.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Female
Humans
Lung Neoplasms
Male
Randomized Controlled Trials as Topic
authors with profiles
Everett Vokes
Ravi Salgia
Theodore Karrison